Individuals co-infected with HIV and hepatitis C virus are at risk for diabetes and insulin resistance. Some population based surveys have shown that cannabis (marijuana) use decreases that risk in this population.
This study evaluated medical data for 703 individuals co-infected with HIV and hepatitis C over a period of 60 months and where at least 1 follow-up visit demonstrated insulin resistance.
45% of these reported cannabis use at least once prior to the first visit evaluated. This study shows that regardless of frequency of use, marijuana users in this group were less likely to have insulin resistance.
